As an academic health science centre, Sinai Health fosters a culture where everyone is a learner. We believe that the combination of energy, fresh thinking and knowledge transfer is a reciprocal relationship that benefits the hospital, the student – and ultimately our patients.
As an academic health science centre, Sinai Health fosters a culture where everyone is a learner. We believe that the combination of energy, fresh thinking and knowledge transfer is a reciprocal relationship that benefits the hospital, the student – and ultimately our patients.
Researchers from Sinai Health have uncovered that growing up with a dog is associated with a decreased risk of developing Crohn's disease.
Their research shines new light on how environmental factors influence the onset of this inflammatory bowel condition and could inform future prevention strategies.
The research was led by Dr. Kenneth Croitoru, a Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health, and Dr. Williams Turpin, a Research Scientist at Sinai Health. Drs. Croitoru and Turpin are also part of Mount Sinai Hospital’s Centre for Inflammatory Bowel Disease (IBD), one of the largest centres globally dedicated to researching and treating IBD.
The team investigated how dozens of environmental factors impact the likelihood of developing Crohn’s as part of their overarching effort to be able to predict those at risk and potentially intervene early.
“The idea behind predicting someone's risk of disease is that you can then also begin to understand who you might want to do something to, to try and prevent disease,” said Dr. Croitoru, who holds the Canada Research Chair in Inflammatory Bowel Diseases.
Conversely, people who lived with a bird at the time of study were more likely to get Crohn’s.
Image
Dr. Kenneth Croitoru
“We don’t know why living with a dog makes someone less prone to Crohn’s disease, but this is what our data shows,” said Dr. Croitoru, who is also a gastroenterologist at Mount Sinai Hospital.
“We have established associations between environmental factors and Crohn’s and are now trying to understand how these environmental factors affect the triggering the disease.”
Caused by inflammation in the gastrointestinal tract, Crohn’s disease can have far-reaching consequences on overall health and well-being. Its incidence among children under 10 has doubled since 1995, while the annual cost of IBD to Canada is estimated at $5.4 billion per year, according to Crohn’s and Colitis Canada, a non-profit dedicated to finding cures for the most common types of inflammatory bowel disease.
The likelihood of getting Crohn’s is strongly influenced by genetics, but the environment also plays a role. While we can’t change our genes, we can modify our surroundings and diet, for example, to potentially prevent the disease from occurring, said Dr. Croitoru.
These findings come from the Genetic, Environmental and Microbial (GEM) Project, the largest study of its kind that seeks to identify potential triggers of Crohn’s disease. Coordinated at Mount Sinai Hospital since 2008, the GEM has been collecting comprehensive medical and lifestyle data from over 5,000 healthy first-degree relatives of people who have Crohn’s and come from all over the world, including Australia, Canada, Israel, New Zealand, U.K., and the U.S.
In the 15 years since the study began, over 120 people have developed the disease.
“By understanding what is different about those who develop the disease, we should be able to predict who is at risk,” said Dr. Croitoru.
But risk prediction is only the first step, said Dr. Croitoru, whose ultimate goal is to be able to intervene and prevent the disease from starting. They are now doing research that seeks to devise and test strategies for prevention by, for example, adding supplements to the diet to promote a healthy microbiome.
“Sinai Health is committed to groundbreaking research and bringing those discoveries to patients. By integrating genetic, environmental, and microbial data, Dr. Croitoru and colleagues are paving the way towards personalized intervention strategies that could significantly reduce the incidence of Crohn’s disease," said Dr. Anne-Claude Gingras, Director for the Lunenfeld-Tanenbaum Research Institute and Vice-President of Research for Sinai Health.
The GEM Project has been funded by the Crohn’s and Colitis Canada, the Canadian Institutes of Health Research and the Helmsley Charitable Foundation.
